REVESTIVE 5 mg, powder and solvent for solution for injection bottle, 0.5 ml
Active ingredients: Teduglutide
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for injectionbottle, 0.5 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- REVESTIVE 5 mg, poudre et solvant pour solution injectable
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 flacon(s) en verre - 1 seringue(s) préremplie(s) en verre de 0,5 ml avec piston(s)
- Marketing authorisation holder
- TAKEDA PHARMACEUTICALS INTERNATIONAL (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Apr 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
64929099CIP73007861CIP133400930078617Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TÉDUGLUTIDEpoudre | 5 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.